With new research in immunotherapy and targeted therapy, treatment options for blood cancer patients are rapidly expanding. Combination therapies have also caused much excitement among researchers and physicians, and ongoing clinical trials are continuing to look at new strategies that use multiple drugs for fighting these diseases.
In this Cancer Conversations podcast episode, Irene Ghobrial, MD, and Matthew Davids, MD, of Dana-Farber’s Hematologic Oncology Treatment Center, discuss some of these new treatments and clinical trials for multiple myeloma, leukemia and other blood cancers.
Listen to the podcast episode below or click “download” to listen later. Subscribe options are also available via iTunes, Google Play and RSS.
The Cancer Conversations series features Q&A-style conversations with Dana-Farber physicians, clinicians, and researchers. Topics include breast cancer research, precision cancer medicine, integrative therapies, cancer genetics, and more. Visit the Cancer Conversations page for more episodes.